Investigation of Simulations Plus by Johnson Fistel: A Cautionary Tale for Investors
In recent developments, Johnson Fistel, PLLP, a well-known shareholder rights law firm, has announced an investigation into Simulations Plus, Inc. (NASDAQ: SLP). The firm is looking into possible violations of securities laws and is encouraging affected investors to step forward and share their experiences. This inquiry comes amid a backdrop of concerning financial performance and unanticipated company disclosures that have significantly impacted investor confidence.
The situation first gained traction when Simulations Plus revealed its financial results for the second quarter of fiscal 2025 on April 3, 2025. At that time, the company maintained its optimistic revenue guidance of $90 million to $93 million for the full fiscal year. However, this optimism took a downturn by June 11, 2025, when it had to announce preliminary figures for the third quarter, advising a grim downward revision of its full-year revenue forecast to between $76 million and $80 million. The main culprits for this revised outlook included budget slashes, project cancellations, and delays faced by its pharmaceutical and biotechnology clientele due to an unstable market.
This sudden shift in financial guidance sent shockwaves through the investor community, causing Simulations Plus's stock to plummet over 24%, from $26.44 to $20.05 per share. Investors were left reeling from the unexpected drastic changes and started to question the company's previous assurances regarding its financial health.
Compounding these issues, on July 14, 2025, Simulations Plus reported its financial results for the third quarter, revealing a staggering net loss of $67.3 million, equating to $3.35 per diluted share. Factors that contributed to this dismal performance included a significant non-cash impairment charge of $77.2 million. To make matters worse, the following day, the company disclosed the dismissal of Grant Thornton LLP, its independent registered public accounting firm. The main concerns revolved around unresolved issues in segment reporting, reporting-unit determinations, and internal control over financial reporting, signaling deeper problems within the company.
Additionally, Grant Thornton sent a letter to the Securities and Exchange Commission (SEC) disagreeing with specific elements of Simulations Plus's disclosures. They indicated that essential matters pertaining to the company’s financial practices had not been addressed satisfactorily before their departure. The fallout from these revelations saw Simulations Plus's stock spiral downward nearly 26%, dropping from $17.47 to $12.97 per share.
Given these troubling developments, Johnson Fistel is inviting current and former investors who have suffered losses in relation to their investment in Simulations Plus to consider joining the investigation. The firm emphasizes that there are no costs or obligations to participate, and doing so could provide investors with essential information regarding their legal rights. For anyone who purchased Simulations Plus securities and suffered financial losses, the opportunity exists to explore potential legal recourse.
Johnson Fistel, PLLP operates nationwide from multiple offices, including locations in California, New York, Georgia, Idaho, and Colorado. The firm has established a solid reputation advocating for both individual and institutional investors in shareholder derivative and securities class action lawsuits. In recent years, it has been recognized as a top firm in its field, recovering approximately $90.7 million for investors in 2024 alone.
As this investigation unfolds, the situation presents a critical case study on the importance of transparency and integrity within corporate financial communications. Investors are urged to remain vigilant and informed, especially when market fluctuations and internal management issues can drastically affect stock values and investment strategies. For those interested in learning more about the investigation or participating, additional details are available on Johnson Fistel's official website.
The situation first gained traction when Simulations Plus revealed its financial results for the second quarter of fiscal 2025 on April 3, 2025. At that time, the company maintained its optimistic revenue guidance of $90 million to $93 million for the full fiscal year. However, this optimism took a downturn by June 11, 2025, when it had to announce preliminary figures for the third quarter, advising a grim downward revision of its full-year revenue forecast to between $76 million and $80 million. The main culprits for this revised outlook included budget slashes, project cancellations, and delays faced by its pharmaceutical and biotechnology clientele due to an unstable market.
This sudden shift in financial guidance sent shockwaves through the investor community, causing Simulations Plus's stock to plummet over 24%, from $26.44 to $20.05 per share. Investors were left reeling from the unexpected drastic changes and started to question the company's previous assurances regarding its financial health.
Compounding these issues, on July 14, 2025, Simulations Plus reported its financial results for the third quarter, revealing a staggering net loss of $67.3 million, equating to $3.35 per diluted share. Factors that contributed to this dismal performance included a significant non-cash impairment charge of $77.2 million. To make matters worse, the following day, the company disclosed the dismissal of Grant Thornton LLP, its independent registered public accounting firm. The main concerns revolved around unresolved issues in segment reporting, reporting-unit determinations, and internal control over financial reporting, signaling deeper problems within the company.
Additionally, Grant Thornton sent a letter to the Securities and Exchange Commission (SEC) disagreeing with specific elements of Simulations Plus's disclosures. They indicated that essential matters pertaining to the company’s financial practices had not been addressed satisfactorily before their departure. The fallout from these revelations saw Simulations Plus's stock spiral downward nearly 26%, dropping from $17.47 to $12.97 per share.
Given these troubling developments, Johnson Fistel is inviting current and former investors who have suffered losses in relation to their investment in Simulations Plus to consider joining the investigation. The firm emphasizes that there are no costs or obligations to participate, and doing so could provide investors with essential information regarding their legal rights. For anyone who purchased Simulations Plus securities and suffered financial losses, the opportunity exists to explore potential legal recourse.
Johnson Fistel, PLLP operates nationwide from multiple offices, including locations in California, New York, Georgia, Idaho, and Colorado. The firm has established a solid reputation advocating for both individual and institutional investors in shareholder derivative and securities class action lawsuits. In recent years, it has been recognized as a top firm in its field, recovering approximately $90.7 million for investors in 2024 alone.
As this investigation unfolds, the situation presents a critical case study on the importance of transparency and integrity within corporate financial communications. Investors are urged to remain vigilant and informed, especially when market fluctuations and internal management issues can drastically affect stock values and investment strategies. For those interested in learning more about the investigation or participating, additional details are available on Johnson Fistel's official website.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.